Safety of guselkumab in Inflammatory Bowel Disease up to 1 year: Integrated safety analysis of phase 2 and 3 studies in Crohn's Disease and Ulcerative Colitis

被引：0
|
作者：
Sands, B. E. [1 ]
Panaccione, R. [2 ]
Danese, S. [3 ,4 ]
Panes, J. [4 ,5 ]
Hisamatsu, T. [5 ,6 ]
D'Haens, G. [6 ,7 ]
Van Rampelbergh, R. [7 ,8 ]
Olurinde, M. [8 ,9 ]
Yee, J. [8 ,9 ]
Baker, T. [8 ,9 ]
Yarandi, S. [8 ,9 ]
Germinaro, M. [8 ,9 ]
Vetter, M. L. [8 ,9 ]
Li, H. [8 ,9 ]
Ballina, M. Rosas [9 ,10 ]
Allegretti, J. [10 ,11 ,12 ]
Afzali, A. [12 ,13 ]
Rubin, D. T. [13 ]
机构：
[1] Ichan Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, New York, NY USA
[2] Univ Calgary, Div Gastroenterol, Inflammatory Bowel Dis Unit, Calgary, AB, Canada
[3] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
[4] Univ Vita Salute San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
[5] Hosp Clin Barcelona, IDIBAPS CIBERehd, Barcelona, Spain
[6] Kyorin Univ, Sch Med, Med Ctr, Tokyo, Japan
[7] Univ Amsterdam, Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands
[8] Janssen Res & Dev, Immunol, Antwerp, Belgium
[9] Janssen Res & Dev, Immunol, Spring House, PA USA
[10] Actelion Res & Dev, Immunol, Allschwil, Switzerland
[11] Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA USA
[12] Harvard Med Sch, Div Gastroenterol Hepatol & endoscopy, Boston, MA USA
[13] Univ Cincinnati, Coll Med, Cincinnati, OH USA
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0782
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0608
引用
收藏
页码：i1206 / i1208
页数：3
相关论文
共 50 条
  • [31] Chronic inflammatory intestinal diseases:Crohn's disease and ulcerative colitis.: Part 2:: Imaging of ulcerative colitis,treatment of Crohn's disease and ulcerative colitis
    Feuerbach, S
    Scholmerich, J
    RADIOLOGE, 2000, 40 (04): : 415 - 428
  • [32] Long-term Safety Analysis of Vedolizumab for Treatment of Crohn's Disease and Ulcerative Colitis
    Ritter, Timothy E.
    Fourment, Chris
    Van Anglen, Lucinda J.
    Hardin, Thomas C.
    Schroeder, Claudia P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S399 - S399
  • [33] Disease-associated DNA methylationin Inflammatory Bowel Disease subtypes Crohn's disease and Ulcerative Colitis
    Lin, Zhenwu
    Yu, Wei
    Chen, Xi
    Hegarty, John
    Faber, Pieter
    Wang, Yunhua
    Poritz, Lisa
    Fan, Jian-Bing
    Koltun, Walter
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S78 - S78
  • [34] Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis
    Lazaridis, Lazaros-Dimitrios
    Pistiki, Aikaterini
    Giamarellos-Bourboulis, Evangelos J.
    Georgitsi, Marianna
    Damoraki, Georgia
    Polymeros, Dimitrios
    Dimitriadis, George D.
    Triantafyllou, Konstantinos
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (09) : 2348 - 2356
  • [35] Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn’s Disease and Ulcerative Colitis
    Lazaros-Dimitrios Lazaridis
    Aikaterini Pistiki
    Evangelos J. Giamarellos-Bourboulis
    Marianna Georgitsi
    Georgia Damoraki
    Dimitrios Polymeros
    George D. Dimitriadis
    Konstantinos Triantafyllou
    Digestive Diseases and Sciences, 2017, 62 : 2348 - 2356
  • [36] Guselkumab efficacy and safety in East Asian participants with moderate to severely active Crohn's disease: Subgroup analysis of the GALAXI 2 & 3 Phase 3 studies
    Nakase, H.
    Chen, B.
    Cao, Q.
    Matsuoka, K.
    Hisamatsu, T.
    Park, D., I
    Wahking, B.
    Yiu, W. C.
    Zhuo, J.
    Chen, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1612 - I1613
  • [37] EFFICACY AND SAFETY OF GUSELKUMAB THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS OF THE GALAXI 2 & 3 PHASE 3 STUDIES
    Panaccione, Remo
    Danese, Silvio
    Feagan, Brian G.
    D'Haens, Geert
    Afzali, Anita
    Reinisch, Walter
    Panes, Julian
    Rubin, David T.
    Andrews, Jane M.
    Hisamatsu, Tadakazu
    Terry, Natalie A.
    Salese, Leonardo
    Van Rampelbergh, Rian
    Frustaci, Mary Ellen S.
    Yang, Zijiang
    Johanns, Jewel
    Wan, Kitty Y.
    Yee, Jacqueline
    Sands, Bruce E.
    GASTROENTEROLOGY, 2024, 166 (05)
  • [38] Efficacy And Safety of Guselkumab Therapy in Patients With Moderately to Severely Active Crohn's Disease: Results of the Galaxi 2 & 3 Phase 3 Studies
    Panaccione, Remo
    Danese, Silvio
    Feagan, Brian G.
    D'Haens, Geert
    Afzali, Anita
    Reinisch, Walter
    Panes, Julian
    Rubin, David T.
    Andrews, Jane
    Hisamatsu, Tadakazu
    Terry, Natalie A.
    Salese, Leonardo
    Van Rampelbergh, Rian
    Frustaci, Mary Ellen
    Yang, Zijiang
    Johanns, Jewel
    Wan, Kitty Yuen Yi
    Yee, Jacqueline
    Sands, Bruce E.
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2312 - 2318
  • [39] TGF-β1 production in inflammatory bowel disease:: differing production patterns in Crohn's disease and ulcerative colitis
    Del Zotto, B
    Mumolo, G
    Pronio, AM
    Montesani, C
    Tersigni, R
    Boirivant, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 134 (01): : 120 - 126
  • [40] Colorectal carcinoma in inflammatory bowel disease: a comparison between Crohn's and ulcerative colitis
    Averboukh, F.
    Ziv, Y.
    Kariv, Y.
    Zmora, O.
    Dotan, I.
    Klausner, J. M.
    Rabau, M.
    Tulchinsky, H.
    COLORECTAL DISEASE, 2011, 13 (11) : 1230 - 1235
12345